Literature DB >> 28755944

Health-promoting benefits of low-fat akawi cheese made by exopolysaccharide-producing probiotic Lactobacillus plantarum isolated from camel milk.

Ayesha S Al-Dhaheri1, Reem Al-Hemeiri2, Jaleel Kizhakkayil1, Anas Al-Nabulsi3, Aisha Abushelaibi2, Nagendra P Shah4, Mutamed Ayyash5.   

Abstract

Lactic acid bacteria isolated from camel milk exhibit remarkable probiotic and exopolysaccharide (EPS)-producing characteristics. The health-promoting benefits of exopolysaccharide-producing probiotic Lactobacillus plantarum isolated from camel milk used for making low-fat akawi cheese were investigated. Three low-fat akawi cheeses were made using traditional culture (non-EPS-producing, EPS-), commercial EPS-producing (MEPS+), and camel milk EPS-producing (CEPS+) cultures. α-Amylase and α-glucosidase inhibitory activities, antioxidant activities, angiotensin-converting enzyme (ACE) inhibition, and antiproliferative activity were determined. Cheese made with CEPS+ culture exhibited comparable α-amylase inhibition to that of cheeses made with MEPS+. Scavenging rates of cheese made with EPS+ cultures were higher than those of cheese made with EPS- cultures. The percentage of α-glucosidase inhibition ranged from >45% at 0 d to ∼55% at 21 d of storage. After 7 d of storage, the scavenging rate in CEPS+ cheese increased >60% by ABTS assay [2,2'-azino-bis(3-ethylbenzo-thiazoline-6-sulfonic acid)] and >20% by DPPH assay (1,1-diphenyl-2-picrylhydrazyl). Throughout storage, cheese made with EPS+ cultures showed higher ACE-inhibition activity compared with EPS- cultures. Cheese made with CEPS+ showed ACE inhibition >70% after 7 d of storage. Antiproliferation activity of CEPS+ cheese increased from 38 to 48% during 7 d of storage and was maintained above 45% with prolonged storage. Low-fat akawi cheese produced with these cultures exhibited similar or greater health-promoting benefits compared with cheese made using commercial starter cultures. Therefore, incorporation of these cultures in food is promising for commercial uses.
Copyright © 2017 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antiproliferative; exopolysaccharide (EPS); health-promoting benefit; probiotic

Mesh:

Substances:

Year:  2017        PMID: 28755944     DOI: 10.3168/jds.2017-12761

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  5 in total

Review 1.  Biological Functions of Exopolysaccharides from Lactic Acid Bacteria and Their Potential Benefits for Humans and Farmed Animals.

Authors:  María Laura Werning; Annel M Hernández-Alcántara; María Julia Ruiz; Lorena Paola Soto; María Teresa Dueñas; Paloma López; Laureano Sebastián Frizzo
Journal:  Foods       Date:  2022-04-28

2.  Microbiota Associated with Dromedary Camel Milk from Algerian Sahara.

Authors:  Tahar Amrouche; Jérôme Mounier; Audrey Pawtowski; Florian Thomas; Adeline Picot
Journal:  Curr Microbiol       Date:  2019-10-26       Impact factor: 2.188

3.  Bioactive Properties of Novel Probiotic Lactococcus lactis Fermented Camel Sausages: Cytotoxicity, Angiotensin Converting Enzyme Inhibition, Antioxidant Capacity, and Antidiabetic Activity.

Authors:  Mutamed Ayyash; Amin Olaimat; Anas Al-Nabulsi; Shao-Quan Liu
Journal:  Food Sci Anim Resour       Date:  2020-03-01

4.  Assessment of exopolysaccharide production by Lactobacillus delbrueckii subsp. bulgaricus ropy strain in different substrate media.

Authors:  Ratmawati Malaka; Fatma Maruddin; Zaraswati Dwyana; Maynor V Vargas
Journal:  Food Sci Nutr       Date:  2020-02-20       Impact factor: 2.863

Review 5.  Effect of Camel Milk on Glucose Homeostasis in Patients with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Refat AlKurd; Nivine Hanash; Narmin Khalid; Dana N Abdelrahim; Moien A B Khan; Lana Mahrous; Hadia Radwan; Farah Naja; Mohamed Madkour; Khaled Obaideen; Katia Abu Shihab; MoezAlIslam Faris
Journal:  Nutrients       Date:  2022-03-15       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.